ArticlePhysica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)2026
An integrated PET/CT simulation framework for virtual imaging trials and quantitative performance evaluation.
Article in Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThe purpose of this study was to demonstrate the use of integrated PET/CT virtual imaging trials (VITs) for evaluating PET/CT acquisition protocols and clinically relevant sources of PET quantification variability under controlled, repeatable conditions.
methodsAn integrated PET/CT simulation framework was developed by combining SimSET for PET and DukeSim for CT, enabling concordant multi-modality simulations from a single human model input, including CT-derived attenuation correction. Geometric concordance was verified using an in-silico PET/CT coregistration test. Validation employed a NEMA IEC body phantom by comparing simulated PET/CT images with clinical scans using standard uptake value (SUV) and contrast recovery coefficient (CRC) metrics. Application studies assessed respiratory phase mismatch between PET and CT acquisitions, the impact of CT protocol selection on attenuation correction for free-breathing PET, and CT dose-reduction strategies for attenuation correction.
resultsGeometric concordance was achieved with a maximum PET/CT centroid difference of 1.83 mm. Phantom validation demonstrated agreement between simulated and clinical PET quantification, with SUV measurements within 6% using CT-derived attenuation correction and within 12% using an ideal attenuation map. Application studies revealed that respiratory phase mismatch and CT protocol selection can produce clinically significant differences in PET quantification metrics. Dose-reduction studies showed minimal sensitivity of PET quantification to ultra-low-dose CT attenuation correction, with CRC deviations ≤ 0.23% across CT conditions for the same sphere size.
conclusionThe integrated PET/CT simulation framework enables virtual imaging trials for controlled and reproducible investigations of PET/CT protocols, supporting multi-modality imaging optimization and quantitative performance evaluation under clinically relevant conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.